ERBB2 and cancer: The majority of the 39 monogenic rare variant containing genes are either well-known tumor suppressors or suspected to have a tumor suppressor role, whereas only PPM1D and ERBB2 are classified as bonafide oncogenes by the Cancer Gene Census [24].